Relating to collaborative pharmacy practice allowing pharmacists to provide patient care and drug therapy management services

Where it is now

1. ✓
   Done: IntroducedJanuary 28, 2019
2. ✓
   Done: SubcommitteeJanuary 29, 2019
3. ✓
   Done: Senate committeeFebruary 18, 2020
4. –
   Skipped: Passes the SenateContinued as SF 2318
5. Next: House committee
6. Next: Passes the House
7. Next: To the Governor
8. Next: Signed into law

Became SF 2318 → Its progress continues under the new number. Go to SF 2318 What’s a funnel?

What’s in it

This bill allows a pharmacist to engage in a collaborative pharmacy practice, in accordance with administrative rules adopted by the board of pharmacy and under a collaborative pharmacy practice agreement, to provide patient care and drug therapy management services to a patient including a patient following a behavioral health diagnosis by a practitioner. The bill also provides that if a health benefit plan provides for payment or reimbursement for a service that is within the lawful scope of practice of a practitioner or pharmacist and the service is provided by a pharmacist pursuant to a collaborative pharmacy practice agreement, the health carrier may provide payment or reimbursement for the service.

Full bill text¹

Senate subcommittee

Named January 16, 2020. On January 23, 2020 it recommended amendment and passage.

• Sen. Thomas A. Greene R
• Sen. Julian B. Garrett R
• Sen. Liz Mathis D

Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part

Family tree